GSK's Covid-19 Valentine to Vir Biotech: 'You Can Go Your Own Way'
GSK gave Vir Biotechnology a Valentine’s Day break-up message, but it’s not a complete goodbye. Though the two companies are ending their Covid-19 collaboration, they’ll still work together on other respiratory programs, including a prophylactic influenza antibody drug that is in mid-stage clinical development.
United Kingdom Tony Wood George Scangos Though Curevac Chief Scientific Officer Tony Wood Weight Loss
Source: medcitynews.com